Announcements
- ONWARD® Medical plant Webcast zur Vorstellung des Geschäftsverlaufs im 1. Quartal 2024
- ONWARD® Medical organise un webinaire pour présenter l’état des lieux de ses activités du premier trimestre 2024
- ONWARD® Medical Schedules Webcast to Provide Q1 2024 Business Update
- Avis de convocation à l’assemblée générale 2024 des actionnaires ONWARD® et propositions de résolutions
- ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resolutions
- ONWARD® Medical annonce ses résultats financiers et opérationnels pour l’exercice 2023 et partage les faits qui ont marqué l’exercice 2024 à ce jour
- ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date
- ONWARD® Medical Announces Publication of Full Year 2023 Financial Results and Business Update Webcast
- Stifel Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 12.00
- ONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® System
More ▼
Key statistics
On Friday, ONWARD Medical NV (63E:DUS) closed at 4.74, 10.23% above the 52 week low of 4.30 set on Feb 29, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.74 |
---|---|
High | 4.74 |
Low | 4.74 |
Bid | 4.80 |
Offer | 5.08 |
Previous close | 4.68 |
Average volume | 0.00 |
---|---|
Shares outstanding | 34.63m |
Free float | 28.07m |
P/E (TTM) | -- |
Market cap | 170.37m EUR |
EPS (TTM) | -1.20 EUR |
Data delayed at least 15 minutes, as of May 17 2024 07:12 BST.
More ▼